UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)
    [X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
         ACT OF 1934

                For the quarterly period ended September 30, 2002
                                               ------------------

    [ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

             For the transition period from __________ to___________

                          Commission file number 0-5186



                              OCG TECHNOLOGY, INC.
        -----------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)




                DELAWARE                                    13-2643655
     -------------------------------                    -------------------
     (State or other jurisdiction of                      (IRS Employer
      incorporation or organization)                    Identification No.)



                56 Harrison Street, New Rochelle, New York 10801
                ------------------------------------------------
                    (Address of principal executive offices)



                                 (914) 576- 8457
                           ---------------------------
                           (Issuer's telephone number)



   ---------------------------------------------------------------------------
   (Former name, address and former fiscal year, if changed since last report)


Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. [X] Yes [ ] No



State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

             Class                     Shares Outstanding at November 6, 2002
  -----------------------------        --------------------------------------
  Common Stock ($.01 par value)                41,073,613 Shares



                      OCG TECHNOLOGY, INC. AND SUBSIDIARIES


                                      INDEX


PART I. - FINANCIAL  INFORMATION                                   PAGE NUMBER
- --------------------------------                                   -----------

Consolidated Condensed Balance Sheets
September 30, 2002 and June 30, 2002                                    1

Consolidated Condensed Statements of Loss for the
Three  Months Ended September 30, 2002 and 2001                         2

Consolidated Condensed Statements of Cash Flow for
the Three Months Ended September 30, 2002 and 2001                      3

Notes to Consolidated Condensed Financial Statements                    4

Management's Discussion and Analysis of
Financial Condition and Results of Operations                           5


PART II - OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K                             11




                      OCG TECHNOLOGY, INC. AND SUBSIDIARIES
                      CONSOLIDATED CONDENSED BALANCE SHEETS




                                                              September 30,     June 30,
                                                                  2002            2002
                                                              ------------    ------------
ASSETS                                                         (UNAUDITED)      (AUDITED)
                                                                        
Current Assets:
      Cash                                                    $      1,424    $     37,191
      Accounts receivable                                              326             326
      Inventory                                                     13,163          14,531
      Other current assets                                          17,961          44,877
      Notes receivable                                             334,500         325,000
      Interest receivable                                           16,541           8,362
                                                              ------------    ------------
Total current assets                                               383,936         430,287

Property and equipment, net of accumulated depreciation of
             ($609,289)             ($601,590)                      26,713          27,061

Capitalized software costs, net of accumulated amortization
             ($231,277)             ($139,939)                     439,160         426,826
                                                              ------------    ------------
            Total assets                                      $    854,781    $    889,146
                                                              ============    ============

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
      Accounts payable and accrued expenses                         56,473          52,599
      Bank loans payable                                            16,967
Other liabilities:
      Notes Payable - long term                                    279,500         239,500
                                                              ------------    ------------
                    Total liabilities                              352,940         292,099
                                                              ------------    ------------

Shareholders' equity: (Note 4)
      Preferred stock $.10 par value, Series C                       6,000           6,000
      Preferred stock $.10 par value, Series E                       3,333           3,333
      Common stock $.01 par value                                  410,736         391,736
      Additional paid-in capital                                25,663,759      25,486,759
      Accumulated deficit                                      (25,273,987)    (25,486,281)
      Stock subscriptions receivable                              (245,500)        (65,000)
                                                              ------------    ------------
                                                                   564,341         724,547

      Less: treasury stock, at cost (12,500 shares)                (62,500)        (62,500)
                                                              ------------    ------------
                     Total shareholders' equity                    501,841         724,547
                                                              ------------    ------------
Total liabilities and shareholders' equity                    $    854,781    $    889,146
                                                              ============    ============


See accompanying notes to consolidated condensed financial statements


                                        1



                      OCG TECHNOLOGY, INC. AND SUBSIDIARIES
                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



                                                                       Three Months Ended
                                                                          September 30,
                                                                  ----------------------------
                                                                      2002            2001
                                                                  ------------    ------------
                                                                            
Revenue:
          Sales                                                   $     47,345    $     24,909
                                                                  ------------    ------------

Costs and expenses:
          Cost of sales                                                 24,955               0

          Marketing, general and administrative                         56,828          43,513
          Depreciation and amortization                                 39,036          25,135
          Product development costs                                     43,841         130,922
          Interest - net                                                (6,609)           (476)
                                                                  ------------    ------------
Total costs and expenses                                               158,051         199,094
                                                                  ------------    ------------

Net profit (loss)                                                     (110,706)       (174,185)
                                                                  ============    ============

Weighted average number of shares outstanding during the period     39,890,493      32,320,485
                                                                  ============    ============

Loss per Common Share                                             $      (0.01)   $      (0.01)
                                                                  ============    ============


See accompanying notes to consolidated condensed financial statements


                                        2



                      OCG TECHNOLOGY, INC. AND SUBSIDIARIES
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)



                                                                                    Three Months Ended
                                                                                       September 30,
                                                                               ----------------------------
                                                                                   2002            2001
                                                                               ------------    ------------
                                                                                         
Cash flows from operating activities:
          Net income (loss)                                                    ($   110,706)   ($   135,077)
                                                                               ------------    ------------
          Adjustments to reconcile net income (loss)
                       to net cash used in operating activities:
                  Depreciation and amortization                                      39,036          30,851
                  Issuance of stock and warrants for services                         6,000           6,000

          Changes in assets and liabilities
                  (Increase) decrease in receivables                                 (8,179)          7,210
                  (Increase) decrease in notes receivables                           (9,500)
                  (Increase) decrease in other current assets                        26,896          84,736
                  (Increase) decrease in inventory                                    1,368          (8,856)
                  (Increase) decrease in accounts payable and
                   accrued expenses                                                   3,874          (6,722)
                                                                               ------------    ------------

                                 Total adjustments                                   59,495         113,219
                                                                               ------------    ------------

                                 Net cash used in operating activities              (51,211)        (21,858)
                                                                               ------------    ------------

Cash flows from investing activities:
             Capitalized software development costs                                 (43,673)        (33,412)
              (Increase) decrease in property and equipment                          (7,350)

Cash flows from financing activities:
              Increase (decrease) in notes payable                                   40,000         101,000
              Increase (decrease) in bank loans                                      16,967           8,000
              Proceeds from sale of common stock                                    190,000
              (Increase) decrease in subscriptions receivable                      (180,500)
                                                                               ------------    ------------

                                 Net cash changes from investing & financing         15,444          75,588
                                                                               ------------    ------------

Net increase (decrease) in cash                                                     (35,767)         53,730

Cash, beginning of period                                                            37,191           7,774
                                                                               ------------    ------------

Cash, end of period                                                            $      1,424    $     61,504
                                                                               ============    ============


See accompanying notes to consolidated condensed financial statements


                                        3



                      OCG TECHNOLOGY, INC. AND SUBSIDIARIES
              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
                                   (UNAUDITED)


1.       In the opinion of the Company, (which, together with its subsidiaries,
unless the context otherwise requires, is referred to as "OCGT"), the
accompanying unaudited consolidated condensed financial statements contain all
adjustments (consisting of only normal recurring adjustments) necessary to
present fairly the financial position as of September 30, 2002 and the results
of operations for the three months ended September 30, 2002 and 2001 and the
statements of cash flows for the three months ended September 30, 2002 and 2001.
The June 30, 2002 balance sheet has been derived from the Company's audited
financial statements.

         The results of operations for the three months ended September 30, 2002
are not necessarily indicative of the results to be expected for the full year.

         While the Company believes that the disclosures presented are adequate
to make the information not misleading, it is suggested that these condensed
financial statements be read in conjunction with the financial statements and
the notes thereto included in the Company's latest annual report on Form 10-KSB.

         The accompanying consolidated financial statements have been prepared
on a going concern basis which contemplates continuity of operations and
realization of assets and liquidation of liabilities in the ordinary course of
business. Because of significant operating losses, the Company's ability to
continue as a going concern is dependent upon its ability to obtain sufficient
additional financing and, ultimately, upon future profitable operations. The
financial statements do not include any adjustments relating to the
recoverability and classification of recorded asset amounts or the amounts and
classification of liabilities that might be necessary should the Company be
unable to continue in existence.

2.       Earnings per share is computed using the weighted average number of
shares outstanding during the periods. The effect of warrants outstanding would
be anti-dilutive.

3.       Other assets decreased due primarily to the amortization of the value
previously assigned under a Black Scholes calculation to warrants issued for
marketing and corporate services to be rendered and rent and other services.
This value continues to be amortized over the life of the services rendered .

4.       Capital Changes:

         During the three months ended September 30, 2002, for services rendered
in accord with the terms of a consulting agreement, warrants were issued to
purchase a total of 15,000 shares of the Company's common stock at exercise
prices ranging between $0.15 to $0.25 per share with exercise dates of said
warrants expiring between July 1 to September 1, 2004. The Company reflected a
total expense of $6,000 for the three month period ending September 30, 2002.

         During the three months ended September 30, 2002, warrants were
exercised to purchase an aggregate of 1,900,000 shares of the Company's common
stock at an exercise price $0.10 per share.



                                        4



                      CG TECHNOLOGY, INC. AND SUBSIDIARIES
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

           A SUMMARY OF INCREASES (DECREASES) IN THE ITEMS INCLUDED IN
               THE CONSOLIDATED STATEMENTS OF LOSS IS SHOWN BELOW:


General
- -------
The following discussion and analysis should be read in conjunction with the
Consolidated Financial Statements and Notes thereto appearing elsewhere herein.
The following discussion contains certain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 and OCGT intends that such forward-looking
statements be subject to the safe harbors created thereby. These forward-looking
statements include predictions, estimates and other statements that involve a
number of risks and uncertainties. While this outlook represents OCGT's current
judgment on the future direction of the business, such risks and uncertainties
could cause actual results to differ materially from any future performance
suggested herein.

OCGT has experienced recurring losses from operations and has relied on the sale
of equity interests in OCGT to fund its operations. If necessary, OCGT intends
to provide additional working capital through the sale of equity interests in
OCGT. Although, in the past, OCGT has been able to provide working capital
through the sale of equity interests in OCGT, there can be no assurances that
OCGT will succeed in its efforts, which creates a doubt about its ability to
continue as a going concern. The results of operations for prior periods is
based on OCGT's continuing operations.

Results of Operations
- ---------------------
Total revenues increased $22,436 for the three months ended September 30, 2002
as compared to the same period for 2001 primarily as a result of a change in
marketing methods of Web site sales. In prior years, income from Web site sales
was "commissions". In the fall of 2001, inventory was purchased for Web site
sales and as a result the revenues increased and the cost of sales was $24,955
for the three months ended September 30, 2002. The sales of OCG Technology, Inc.
("OCGT"), and Prime Care Systems, Inc ("PSI"), a subsidiary of OCGT, were $0 and
$47,345 respectively, for the three months ended September 30, 2002.

Marketing, general and administrative expenses increased $13,315 for the three
months ended September 30, 2002 as compared to the same period for 2001
primarily as a result of the increase of expenditures for business development.

Liquidity and Capital Resources
- -------------------------------
At September 30, 2002, OCGT had a current ratio of .54 to 1 compared to .57 to 1
as of September 30,2001. The net loss from operations for the three months ended
September 30, 2002, was $110,706 of which loss from non-cash charges of $71,932
accounted for 65% of the total loss from operations. OCGT has experienced
recurring losses from operations and has been unable to provide sufficient
working capital from operations and has relied on the sale of equity interests
in OCGT, the exercise of warrants and loans from shareholders to fund its
operations. OCGT's auditors have included an explanatory paragraph regarding the
ability of OCGT to continue as a "going concern".


Cash on hand and accounts receivable were $1,750 at September 30, 2002. OCGT
also has $245,500 of demand notes receivable related to the exercise of
warrants. In the past, OCGT's principal means of overcoming its cash shortfalls
from operations was from the sale of OCGT's common stock, the exercise of
warrants and loans from shareholders. During the three months ended September
30, 2001, OCGT received $40,000 in loans from shareholders. Although, in the
past, OCGT has been able to provide working capital through the sale of equity
interests in OCGT, loans from shareholders and through the exercise of warrants,
there can be no assurances that OCGT will succeed in its efforts.


                                        5


Notes receivable
- ----------------
OCGT has advanced funds totaling $334,500, plus accrued interest at 7% per
annum, pursuant to a grid note, dated February 4, 2002. In consideration for
these advances, OCGT received warrants to purchase common stock of the borrower,
exercisable over a period of three years from the date of issuance, at a price
of $0.25 per share. OCGT received a security interest in accounts receivable of
the borrower anticipated to be generated under certain sales contracts which
provide for borrower to install and maintain the healthcare system for certain
countries. OCGT is also a subcontractor of the borrower.

Products and Competition
- ------------------------
OCGT's revenues are primarily derived through its wholly owned subsidiary
PrimeCare Systems, Inc.(" PSI"), which developed, owns and maintains the
PrimeCareTM Patient Management System ("the PrimeCareTM System"), which is
protected by copyrights. (hereafter "OCGT" shall mean OCGT and/or PSI as the
context requires).

Products:
- ---------
OCGT markets the PrimeCareTM System, the CodeComplierTM and Internet enhanced
versions of parts of the PrimeCare(TM) System on the following Web sites
(1)YourOwnDoctor.com, (2) PrimeCareOnTheWeb.com and (3)YourOwnHealth.com. OCGT
also created, maintains and markets a Web site known as DeniseAustin.com. OCGT
will shortly be offering the PrimeCare(TM) System Version 9 ("PrimeCare Version
9"). PrimeCare Version 9 is a complete, ground-up redesign and re-write of the
entire PrimeCareTM System undertaken during this past fiscal year.

PrimeCare's Version 9 reduces installation and maintenance costs and has great
flexibility which enables it to be adapted to a wide variety of health care
organizational uses, i.e., national and local health care systems, military
organizations, correctional facilities, HMOs, hospitals with outpatient
services, clinics, group practices and solo practitioners.

OCGT products are unique and are of significant benefit to healthcare providers
and their patients, consumers, pharmaceutical companies and other companies in
the healthcare industry and fitness field. Physicians agree that the most
important and time consuming part of any medical encounter is the collection of
the patient's detailed history of present illness ("HPI"). Most physicians agree
that in as many as 8 of every 10 patients, the diagnosis can be obtained from a
detailed HPI. Amongst many other benefits, the PrimeCareTM System is of great
aid to the physician in obtaining the HPI.

Products:
- --------

         PrimeCareTM Patient Management System ("the PrimeCareTM System") is an
in-office client server based, user friendly, patient management system, and,
also, is uniquely patient interactive, as well as physician and staff
interactive. The PrimeCareTM System: (i) creates an electronic medical record
documenting the patient/physician encounter; (ii) is compatible with practice
management and billing systems; (iii) is Health Insurance Portability
Accountability Act ("HIPAA") compliant; (iv) is designed for use in ambulatory
clinics, group and individual practices; (v) uses an authoritative and
comprehensive knowledge database of approximately 280 symptom and problem
oriented patient questionnaires (the "Questionnaires") used to obtain the
patient's history of present illness ("HPI") for diagnostic and follow-up office
visits; (vi) collectively contains over 100,000 complaint and disease state
questions, over 1,600 diagnoses, 1,250 physician reference articles, 1,700
patient education articles; (vii) allows the staff to schedule the appropriate
Questionnaire and enter the vital signs; (viii) interacts directly with the
patient by having the patient select the answers that apply to their problem
from the Questionnaire, in English or Spanish, without requiring physician or
staff time; (ix) does not require the patient to have computer or typing skills;
(x) allows the physician to interact directly with the PrimeCareTM System to
select and document the normal and abnormal physical findings, assessments,
tests, prescriptions and treatment plan for the patient; (xi) automatic (real
time) calculation of HCFA's Evaluation and Management code, with full audit
trail, used for determining the reimbursement level by Medicare and other third
party payors for the office visit; (xii) encrypts all medical data for storage;
(xiii) eliminates dictation and transcription costs; (xiv) reduces risk of
malpractice liability due to errors of omission and "failure to consider"; and
(xv) allows staff to schedule Questionnaires for patient interview via the
Internet using PrimeCareOnTheWeb.


                                        6


The PrimeCareTM System: standardizes the patient record; assures consistency in
patient care; creates a patient database for clinical and outcomes research;
offers, both local and remote, means for utilization review and quality
assurance audits; improves the quality of care; increases efficiency and
productivity of the physician's practice; automatically generates a problem
list; incorporates patient care algorithms and clinical practice guidelines;
permits, both local and remote, on-line electronic retrieval of patient record
and hard copy print out with appropriate security controls; enables rapid access
to important patient data for clinical care; contains and provides patient
education, complaint oriented and medication specific; provides physician
reference materials.

The PrimeCare System is fully functional in current Windows operating
environments including Windows 95, 98, ME, and Windows NT, 2001. PSI's
interfaces enable the PrimeCare(TM) System to communicate with other practice
management systems used in medical facilities. This provides a method for these
systems to transfer information to the PrimeCare(TM) System, such as patient
demographics and appointment scheduling, and the PrimeCare(TM) System to
transfer information (such as billing information including E&M codes, ICD9
codes and CPT codes) to these other systems.

         Code ComplierTM: OCGT has also developed Code ComplierTM an application
software program that was designed to be used in conjunction with the
PrimeCareTM System and PrimeCareOnTheWeb.com. As each item of information is
entered into and collected by the PrimeCareTM System during the patient
encounter, the CodeComplierTM organizes the data in the proper classification
and using the 1997 HCFA guidelines, automatically calculates HCFA's Evaluation
and Management code level, with full audit trail, used for determining the
reimbursement level by Medicare and other third party payors for the History,
Physical Findings and Decision Making sections the office visit. It totally
eliminates the time and effort which would otherwise be required by physician
office personnel to complete this task. CodeComplierTM takes the guess work out
of E&M compliance.

         PrimeCareOnTheWeb.com (the "PCW Site"): The PCW Site is a unique
physician and patient interactive Site that enables physicians to obtain their
patient's detailed HPI by having the patient answer Questionnaires via the
Internet. Like the PrimeCareTM System, PCW produces an extremely comprehensive
HPI that includes all of the "yes" answers, pertinent negatives and a list of
the diagnostic possibilities with the answers that support each diagnostic
consideration. It is HIPAA compliant and protects the confidentiality rights of
every user through a unique user ID and password and the use of secure digital
certificates from VeriSignTM.. All data is encrypted . PCW automatically
provides its registered physicians individual Web sites on YourOwnDoctorTM.com.

         YourOwnDoctor.com (the "YOD Site"): The YOD Site is a web community
created that: (i) provides free individual Web sites for physicians, physician
groups, and other healthcare providers that register for PrimeCareOnTheWebTM;
(ii) enables physicians to promote their services through displaying
credentials, including photos of each physician and staff in the office, listing
specialities, office hours, directions, maps, phone numbers, e- mail addresses,
and accepted insurance plans; (iii) provides useful links to other medical
sites; (iv) provides a direct link from physician site to PCW that enables
patient to access and complete appropriate Questionnaires; and (v) provides
direct link to YourOwnHealth.comTM for use by patients.

         YourOwnHealth.com (the "YOH Site"): The YOH Site is a unique, free
online health and wellness site and empowers healthcare consumers to be better
prepared for their next visit to the doctor. The YOH Site offers: (1) the
"Medical Interview" that: (i) enables visitors to securely and anonymously
select and complete from 110 of the 280 diagnostic problem specific
Questionnaires contained in the PrimeCareTM System; (ii) generates and makes
available to the ste visitor a detailed HPI report based upon their responses;
(iii) permits the visitor to answer the Questionnaires in either English or
Spanish; (iv) encrypts all medical data and uses digital certificates from


                                        7


VeriSignTM for Internet communication; (v) provides banner links to the YOD Site
and www.DeniseAustin.com. (2) "YourOwnHealthTM Notebook": (i) is a secure
depository for storage of personal and family medical data for Registered
Members; (ii) can be accessed only through the use of registered IDs and
Passwords; (iv) provides a convenient way to keep track of personal health
issues such as allergies, immunizations, medications and others that can be kept
and edited on designated lists; (v) allows the Member to save the completed
Questionnaire HPI report and to add personal notes and reminders to the record.
(3) "YourOwnHealthTM Reference" provides extensive healthcare consumer education
material relating to diseases, disease management, medical procedures and
prescription and common over the counter medications, including drug
interaction.

Competition:
- ------------
OCGT has not identified any competitive patient management system which embodies
all the features of the PrimeCare(TM) System, in particular the complaint
specific, interactive Questionnaires completed by the patient and the report
generated by the patient's responses. OCGT believes that it has the only
in-office patient management system and Web sites that enable physicians to
obtain the patient's detailed HPI by having the patient answer problem- specific
HPI Questionnaires on a PC in the office or via the Internet. However, other
companies market systems which may have some of the features of the
PrimeCare(TM) System and some companies market medical office products which
perform different functions than those performed by the PrimeCare(TM) System. To
date, market penetration by both OCGT and its competitors has been very small.

The Market:
- ----------
OCGT's markets for: (a) the PrimeCare System, the PCW Site and the YOD Site are
ambulatory/outpatient medical facilities, such as, primary care physicians,
medical clinics, group practices, health maintenance organizations, and in
general, healthcare providers other than those providing care to patients
confined to hospital beds; and (b) the YOH Site is for the use of the general
public.

According to the American Medical Association, there are in excess of 675,000
physicians in the U.S. OCGT estimates that, of this group, at least 300,000
physicians would benefit from the use of OCGT's healthcare products.

According to a Harris Interactive nationwide survey of practicing physicians
released March 28, 2001,

o      51% of physicians access the Internet from their personal office areas
o      34% of physicians access the Internet in their clinical work areas

It is reasonable, therefore, to assume that, at the present time, 150,000
physicians have the capability to use OCGT's Web sites from their office, and
100,000 can use it from various areas of their office. It should be noted that
the Harris survey is approximately two years old.

The Pew tracking report shows the continuing growth in Internet access, with an
18% increase in the last six months of the year 2001. It is therefore reasonable
to assume that the potential market is currently actually larger and is
continuing to grow.

The Pew Internet & American Life Project: An Internet tracking report, released
on February 18, 2001, stated, "Comparing figures gathered in our tracking survey
in May and June with figures gathered between Thanksgiving and Christmas, we
find that the number of American adults with Internet access grew from about 88
million to more than 104 million in the second half of 2001." This is an 18%
increase in six months.

The Pew Internet & American Life Project: An online life report, released
November 26, 2001, stated that "Fifty-two million American adults, or 55% of
those with Internet access, have used the Web to get health or medical
information." It further stated that, "a majority of them go online at least
once a month for health information. A great many health seekers say the
resources they find on the Web have a direct effect on the decisions they make


                                        8


about their health care and on their interactions with doctors." This report
signifies a very large, continually growing potential market for OCGT's YOH
Site.

Revenue Sources and Marketing Strategy:
- ---------------------------------------
During the prior fiscal year, OCGT's marketing efforts had been concentrated on
its Web products. However, during the fiscal year ended June 30, 2002, the
PrimeCareTM System has been selected to be part of a major, multi-year
international healthcare information management program anticipated to be
installed in a number of countries as their healthcare system. In anticipation
OCGT intensified its efforts to complete PrimeCare Version 9. Successful
completion of these contracts would produce very significant revenues for OCGT.
There can be no assurance, however, that this project will move forward or in
the event that it does, the extent to which the PrimeCareTM System will be used.

Advertising Revenues.
- ---------------------
An article appearing in CNET News.com from Knowledge@Wharton.com, August 7, 2001
stated, ".... Pharmaceutical companies currently spend $2 billion in
direct-to-consumer advertising. Johnson & Johnson has said it will move 40
percent of its ad budget to the Internet. If everyone moves 40 percent to the
Internet, that's almost $1 billion....". This should create the availability of
significant advertising dollars for the Company's Web products which are viewed
by consumers.

Physicians see, on average, 500 patients per month. OCGT believes that this
segment of the healthcare market is capable of generating the greatest activity
at its Web sites and thus, the largest amount of advertising revenues.

In an effort to maximize the healthcare provider's desire to use OCGT's Web
Sites, OCGT devised a marketing strategy which gives each healthcare provider a
share of the revenues generated through that providers use of OCGT's Web
products. In addition, OCGT gives physicians free access to, and use of, its Web
products. Its "revenue sharing" concept is supported by an October 2001 survey,
conducted by Medem, the secure patient-physician e-health network, founded by
the nation's leading medical specialty societies and the American Medical
Association (AMA), released on November 6, 2001, which stated "that physicians
overwhelmingly believe in the value of a robust Web site for their practice. In
addition, half of physicians surveyed said they would be more interested in
using e-mail to communicate with patients if they were reimbursed for it." The
survey also stated, "These results show that physicians embrace the concept of
online communications with their patients if a clear office function is
addressed or an increased office efficiency can be demonstrated." OCGT's
products should meet those criteria.

The fact that the physicians share in the advertising revenues is a strong
motivation for physicians to use OCGT's healthcare Web sites. Their use would
relieve OCGT of the enormous costs normally associated with driving traffic to
Web sites.

The advertising revenue potential from patients viewing impressions on the HPI
Questionnaires may be substantial. Patient interactive HPI Questionnaires
average 25 screen pages per Questionnaire. Each page has room for two
sponsorships by advertisers and up to 7 ad impressions, for a total of 9
impressions per page. Assuming only 5 of the 9 impressions per page are sold at
$.03 per impression (a $30 cost-per-thousand rate), potential revenue per
Questionnaire is $3.75. Physicians average 500 patient visits per month.
Therefore, assuming that a physician spends an aggregate of two months on
vacations, holidays, seminars, conferences, etc. the potential annual ad revenue
per physician using OCGT's PCW is $18,750.Therefore, 1,000 physicians could
generate $18,750,000 per year.

Outcomes Research.
- ------------------
Potentially, OCGT could receive fees for conducting outcomes research for
pharmaceutical companies and teaching hospitals. OCGT anonymizes, encrypts and
stores both the completed diagnostic and follow-up Questionnaires. This
ever-growing medical database can be analyzed in various ways to determine the
effectiveness of treatment plans, medications, etc.

Licensing Fees:
- ---------------
OCGT believes that annual licensing fees from large fixed population groups,
which includes, but is not limited to, labor unions, medical insurance
companies, HMOs, military forces and correctional facilities, can be a source of
revenues.


                                        9


Targeting The Market:
- ---------------------
OCGT is targeting healthcare provider organizations whose physicians can drive
the most traffic to OCGT's Web sites. OCGT is attempting to establish business
relationships with organizations that currently deal with healthcare providers.
These organizations consist of healthcare providers, marketers of software and
hardware, such as, office management system vendors, any other healthcare Web
sites. OCGT would enter into revenue sharing agreements with these
organizations. OCGT currently attempts to recruit and train these organizations
through: (a) its sales and marketing staff; and (b) through independent
consultants. The independent consultants are compensated solely on a commission
basis. OCGT intends to expand its efforts with the launch of PrimeCare Version
9.

The Company has entered into an agreement with Hackensack University Medical
Center ("HUMC"). The agreement provides for the use of the Company's Web sites
by HUMC's medical services organization ("MSO"), North Jersey Medical Management
Services, L.L.C. This MSO has over 1,000 physicians. HUMC, and its Physicians
Hospital Organization, have created www.HUMCMD.net , the only complete
Physician/Patient Internet Service Provider ("ISP") providing top quality
Internet connectivity to members of its physician network, plus access to key
internal HUMC applications.

The HUMCMD site has both a "Physician Portal" and "Patient Portal". The site
currently contains the OCGT's PCW Site and YOH Site. The Company is dependent
upon HUMC's marketing efforts to its Staff Physicians.

OCGT continues to offer the PrimeCare System and the CodeComplier as turnkey
systems within a physician's office.

Fitness Web Site:
- -----------------
OCGT designed, created, operates, maintains and markets a fitness and wellness
Web site known as www.DeniseAustin.com. Through a revenue sharing agreement with
Denise Austin, a nationally known fitness expert who has had a daily fitness
show on television for over 14 years, OCGT promotes and markets a variety of
Denise Austin products on the Web site. Visitors and fans are able to shop
online for their favorite Denise Austin signature exercise videos, books,
equipment, gear, and private label apparel line and nutraceuticals (when
available), as well as sign up for her monthly news letter, enjoy fitness tips,
exercises, motivation messages, and some of her favorite healthy recipes.

         Marketing: OCGT has expanded the comprehensive shopping area on the DA
Web site which offers a broad range of noncompeting products within the fitness
industry. OCGT will share income from two sources - advertising revenues and
e-commerce. YourOwnHealth(TM) is currently positioned at the Denise Austin Web
Site with banners and sponsorship of the monthly newsletter which directs
traffic to YourOwnHealth(TM). YourOwnHealth(TM) intends to take advantage of the
opportunity to position its interactive tools directly from www.DeniseAustin.com
to facilitate a greater increase of traffic.

         Competition: Denise Austin's Daily Workout is reputed to be the number
one fitness show on television with over one million viewers each weekday
morning. Her videos have sold over 4 million copies. OCGT believes that it could
obtain sufficient working capital from operations through marketing its Internet
products, the PrimeCareTM System and CodeComplierTM.

Currently, OCGT has no lines of credit and has no material commitments for
capital expenditures outstanding.


                                       10


                           PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K

         (b)  Reports on Form 8-K
              No Report on Form 8-K, was filed during the quarter ended
              September 30, 2002.


                                       11



                                   SIGNATURES


Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned duly authorized.



                                        OCG TECHNOLOGY, INC.

                                        By /s/ EDWARD C. LEVINE
                                           -------------------------------
                                           Edward C. Levine,
                                           President
                                           (Principal Financial Officer)


DATED:   November 12, 2002


                                       12